Baldini, C., Champiat, S., Vuagnat, P., & Massard, C. (2019). Durvalumab for the management of urothelial carcinoma: A short review on the emerging data and therapeutic potential. Onco Targets Ther.
Chicago-стиль цитированияBaldini, Capucine, Stéphane Champiat, Perrine Vuagnat, and Christophe Massard. "Durvalumab for the Management of Urothelial Carcinoma: A Short Review On the Emerging Data and Therapeutic Potential." Onco Targets Ther 2019.
MLA-цитированиеBaldini, Capucine, Stéphane Champiat, Perrine Vuagnat, and Christophe Massard. "Durvalumab for the Management of Urothelial Carcinoma: A Short Review On the Emerging Data and Therapeutic Potential." Onco Targets Ther 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.